Notably, an increase of Gas6 in the context of Axl inhibition might even fuel ongoing fibrosis, since MerTK activation in Kupffer cells causes NASH-related fibrosis [40]. Here, GAS6 is linked to metabolic dysfunction-associated steatohepatitis.